Rapid Micro Biosystems (RPID) Invested Capital (2020 - 2026)

Rapid Micro Biosystems has disclosed Invested Capital across 5 years of filings, most recently posting $36.9 million for Q2 2026.

• In Q2 2026, Invested Capital changed N/A year-over-year to $36.9 million; the TTM figure through Jun 2026 stood at $36.9 million (changed N/A YoY), while the FY2025 annual figure was $52.1 million, down 30.85% from the prior year.
• Invested Capital came in at $36.9 million for Q2 2026 at Rapid Micro Biosystems, down from $39.5 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $75.4 million in Q4 2024 to a low of $36.9 million in Q2 2026.
• Average Invested Capital over 3 years is $53.4 million, with a median of $52.1 million recorded in 2025.
• The largest YoY upside for Invested Capital was 30.85% in 2025 against a maximum downside of 30.85% in 2025.
• Over 3 years, Invested Capital stood at $75.4 million in 2024, then sank by 30.85% to $52.1 million in 2025, then decreased by 29.21% to $36.9 million in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $36.9 million in Q2 2026, $39.5 million in Q1 2026, and $52.1 million in Q4 2025.